
October 15, 2026
innoscripta SE Expands Clusterix Platform to 14 Countries, Targeting R&D Tax Relief Markets

September 24, 2026
FamiCord AG Signs Manufacturing Agreement with VERIGRAFT for Pivotal Phase II/III Trial of Personalized Tissue-Engineered Vein

September 8, 2026
Scinai Immunotherapeutics Streamlines Operations to Prioritize NanoAb Platform and CDMO Growth









